Pepe G J, Waddell B J, Albrecht E D
Department of Physiology, Eastern Virginia Medical School, Norfolk 23501.
Endocrinology. 1990 Dec;127(6):3117-23. doi: 10.1210/endo-127-6-3117.
We have hypothesized that the change in placental cortisol (F)-cortisone (E) metabolism induced by estrogen late in gestation is important to activation of the baboon fetal hypothalamic-pituitary-adrenocortical axis, culminating in the ontogenesis of de novo F secretion by the fetal adrenal. The present study tested this hypothesis in vivo by comparing the proportion of F in the fetus derived via maternal and fetal production on day 100 (n = 7; term = day 184) and day 165 (n = 4) in untreated baboons and on day 100 in baboons (n = 9) in which 50-mg pellets of androstenedione were implanted sc in the mother in increasing numbers (i.e. two on day 70, four on day 78, six on day 86, and eight on day 94) to increase placental estrogen production. Maternal, uterine, and umbilical venous samples were collected during constant maternal infusion (120 min) of [3H]F/[14C]E, endogenous and radiolabeled F/E content was determined, and corticosteroid dynamics were quantified. The MCR and peripheral interconversion of F and E as well as the production rate of F were unaltered in the mother. However, at midgestation, androstenedione increased (P less than 0.05) estrogen by 62% and altered transuterofeto placental F-E metabolism from preferential reduction of E (%F----E = 17 +/- 4; %E----F = 27 +/- 7) to preferential oxidation of F (%F----E = 26 +/- 2; %E----F = 5 +/- 2), a pattern similar to that at term (%F----E = 32 +/- 6; %E----F = 9 +/- 4). In untreated baboons, on day 100 none of the F in the fetus was due to fetal production, whereas by day 165, 49 +/- 6% was of fetal origin. In animals treated with androstenedione at midgestation, 22 +/- 4% of fetal F was derived de novo within the fetus. Thus, production of F by the fetus was negligible on day 100, increased near term in association with an increase in transplacental oxidation of F to E, and was induced at midgestation in baboons in which placental F-E metabolism was altered by an increase in estrogen production. These findings provide indirect evidence that supports our hypothesis that the change in placental F-E metabolism induced by increasing estrogen late in pregnancy results in activation of the fetal hypothalamic-pituitary-adrenocortical axis and, thus, ontogenesis of fetal F production near term.
我们曾提出假设,即妊娠晚期雌激素诱导的胎盘皮质醇(F)-可的松(E)代谢变化对于激活狒狒胎儿下丘脑-垂体-肾上腺皮质轴至关重要,最终导致胎儿肾上腺从头分泌F的个体发生。本研究通过比较未处理狒狒在第100天(n = 7;足月为第184天)和第165天(n = 4)以及在第100天给狒狒(n = 9)皮下植入数量逐渐增加的50毫克雄烯二酮丸剂(即第70天植入2个,第78天植入4个,第86天植入6个,第94天植入8个)以增加胎盘雌激素分泌后胎儿体内源自母体和胎儿产生的F的比例,在体内对这一假设进行了检验。在母体持续输注(120分钟)[3H]F/[14C]E期间采集母体、子宫和脐静脉样本,测定内源性和放射性标记的F/E含量,并量化皮质类固醇动力学。母体中F和E的代谢清除率、外周相互转化以及F的产生率均未改变。然而,在妊娠中期,雄烯二酮使雌激素增加了62%(P<0.05),并改变了经子宫-胎儿胎盘的F-E代谢,从优先还原E(%F→E = 17±4;%E→F = 27±7)转变为优先氧化F(%F→E = 26±2;%E→F = 5±2),这一模式与足月时相似(%F→E = 32±6;%E→F = 9±4)。在未处理的狒狒中,第100天时胎儿体内的F均非源自胎儿产生,而到第165天时,49±6%是胎儿源性的。在妊娠中期用雄烯二酮处理的动物中,22±4%的胎儿F是在胎儿体内从头产生的。因此,胎儿在第100天时F的产生可忽略不计,临近足月时随着F经胎盘氧化为E的增加而增加,并且在妊娠中期的狒狒中因雌激素产生增加导致胎盘F-E代谢改变而被诱导产生。这些发现提供了间接证据,支持了我们的假设,即妊娠晚期雌激素增加诱导的胎盘F-E代谢变化导致胎儿下丘脑-垂体-肾上腺皮质轴激活,从而在临近足月时胎儿F产生的个体发生。